Boehringer Ingelheim International GmbH
- J05 - Antivirales de uso sistémico
- APTIVUS capsule, soft 250 mg
- APTIVUS oral solution 100 mg/ml
- VIRAMUNE oral suspension 50 mg/5 ml
- VIRAMUNE prolonged-release tablet 100 mg
- N04 - Antiparkinsonianos
- SIFROL prolonged-release tablet 0.26 mg
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- SPIOLTO RESPIMAT pressurised inhalation, solution 25 µg+2.5 µg